Barostim Neo Neuromodulation Device for Heart Failure Wins FDA Approval
 

Barostim Neo Neuromodulation Device for Heart Failure Wins FDA Approval
https://www.medgadget.com/wp-content...neo-device.jpg
CVRx, a Minneapolis, Minnesota company, won FDA approval for the first neuromodulation device designed to address heart failure. Intended as a treatment option for patients with an ejection fraction